Susquehanna International Group
MDCX

Susquehanna International Group’s Medicus Pharma MDCX Stock Holding History

Susquehanna International Group’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,162
Closed -$61.4K – 14394
2025
Q4 		$61.4K Buy
+40,162
New +$86K ﹤0.01% 11680

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group's MDCX Position: Q1 2026 in Review

Susquehanna International Group sold out of Medicus Pharma (MDCX) in Q1 2026, closing a stake of 40,162 shares — an estimated $61.4K sold.

Susquehanna International Group first reported a position in MDCX in Q4 2025 and held it in 1 quarter. The position peaked at $61.4K in Q4 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

  • Susquehanna International Group reported no remaining Medicus Pharma position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 40,162 Medicus Pharma shares in Q1 2026, an estimated $61.4K.
  • Susquehanna International Group first reported a position in Medicus Pharma in Q4 2025 and held it in 1 quarter.
  • Susquehanna International Group's Medicus Pharma position peaked at $61.4K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.